Why it was recalled
Presence of foreign tablets/capsules.
Product description
Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.
Lot numbers, UPCs & expiration codes
Lot#: 5420094, Exp 09/30/2027
Where it was sold
USA Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0473-2025
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- May 23, 2025
- FDA report date
- Jul 2, 2025
- Quantity
- 36612 cartons
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Teva Pharmaceuticals USA, Inc
Original FDA data
Every field from FDA enforcement report D-0473-2025, exactly as published.
Show all FDA fields
- City
- Parsippany
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 96919
- Address
- 400 Interpace Pkwy Bldg A
- Code information
- Lot#: 5420094, Exp 09/30/2027
- Postal code
- 07054-1120
- Report date
- Jul 2, 2025
- Product type
- Drugs
- Recall number
- D-0473-2025
- Classification
- Class II
- Recalling firm
- Teva Pharmaceuticals USA, Inc
- Product quantity
- 36612 cartons
- Reason for recall
- Presence of foreign tablets/capsules.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.
- Distribution pattern
- USA Nationwide
- Recall initiation date
- May 23, 2025
- Initial firm notification
- Letter
- Center classification date
- Jun 20, 2025